|
|
Article: Varian RapidArc Technology Used with Novalis Tx System for First Time Outside U.S. to Treat Head and Neck Cancer Patient.
- Article from:
- Cancer Weekly
- Article date:
- May 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A 51-year old female cancer patient from Switzerland has become the first patient outside the U.S. to be treated with RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE:VAR) on a Novalis Tx(TM) platform for radiosurgery and radiotherapy (see also Cancer).
Doctors at Inselspital, the Bern University Hospital, used the Novalis Tx platform from Varian and BrainLAB to treat a patient suffering simultaneous skin cancer of the nose and an aggressive nasopharyngeal cancer with image-guided IMRT (intensity modulated radiotherapy). The treatment was 'very satisfactory' and compared favourably with conventional treatment techniques, according to ...